CD57+ T cells augment IFN‐γ production in a one‐way mixed lymphocyte reaction and their expansion after stem cell transplantation in paediatric patients
暂无分享,去创建一个
S. Seki | Y. Koike | T. Kaneko | I. Sekine | K. Kogawa | H. Hiraide | S. Fujitsuka | T. Ohkawa
[1] C. Miyaji,et al. Numerical and Functional Characteristics of Lymphocyte Subsets in Centenarians , 1997, Journal of Clinical Immunology.
[2] M. Ritter,et al. Optimal analysis of composite cytokine responses during alloreactivity. , 2002, Journal of immunological methods.
[3] S. Seki,et al. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells , 2001, Immunology.
[4] I. Sekine,et al. Inhibitory effect of serine protease inhibitors on neutrophil‐mediated endothelial cell injury , 2001, Journal of leukocyte biology.
[5] H. Mochizuki,et al. Decrease of CD56+T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma , 2000, Hepatology.
[6] K. Takeda,et al. The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses , 2000, Immunological reviews.
[7] T. Abo,et al. Physiological responses of extrathymic T cells in the liver , 2000, Immunological reviews.
[8] M. Steiner,et al. Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantation , 2000, Bone Marrow Transplantation.
[9] K. Sullivan,et al. Pathophysiology and treatment of graft-versus-host disease. , 1999, Hematology/oncology clinics of North America.
[10] R. Storb,et al. A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients. , 1999, Blood.
[11] D. Doherty,et al. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. , 1999, Journal of immunology.
[12] I. Joosten,et al. Interferon‐γ‐based mixed lymphocyte culture as a selection tool for allogeneic bone marrow donors other than identical siblings , 1999, British journal of haematology.
[13] P. Vandenberghe,et al. CD57+/CD28− T cells in untreated hemato-oncological patients are expanded and display a Th1-type cytokine secretion profile, ex vivo cytolytic activity and enhanced tendency to apoptosis , 1998, Leukemia.
[14] T. Klingebiel,et al. GVHD: overview on pathophysiology, incidence, clinical and biological features. , 1998, Bone marrow transplantation.
[15] G. Trinchieri. Proinflammatory and immunoregulatory functions of interleukin-12. , 1998, International reviews of immunology.
[16] D. Dimitrov,et al. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. , 1997, Blood.
[17] E. Holler,et al. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease , 1997, Bone Marrow Transplantation.
[18] D. Stroncek,et al. Composition of peripheral blood progenitor cell components collected from healthy donors , 1997, Transfusion.
[19] K. Takeda,et al. Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2. , 1996, Journal of immunology.
[20] L. Rink,et al. Interferon-gamma plays a key role in the human mixed lymphocyte culture. , 1996, Bone marrow transplantation.
[21] K. Hatakeyama,et al. Origin of CD57+ T cells which increase at tumour sites in patients with colorectal cancer , 1995, Clinical and experimental immunology.
[22] R. Truitt,et al. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease. , 1995, Blood.
[23] M. Eisner,et al. Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation. , 1995, Bone marrow transplantation.
[24] S. Steinberg,et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. , 1995, The New England journal of medicine.
[25] H. Fukuda,et al. Marked increase of CD8+S6F1+ and CD8+CD57+ cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation. , 1994, Bone marrow transplantation.
[26] F. Sigaux,et al. Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. , 1994, Blood.
[27] H. Watanabe,et al. Extrathymic pathways of T-cell differentiation in the liver and other organs. , 1994, International reviews of immunology.
[28] C. Hillyer,et al. CD34+ progenitors and colony‐forming units‐granulocyte macrophage are recruited during large‐volume leukapheresis and concentrated by counterflow centrifugal elutriation , 1993, Transfusion.
[29] R. Truitt,et al. A decrease in graft-vs.-host disease without loss of graft-vs.-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo. , 1992, Transplantation.
[30] E. Unanue,et al. Natural Immunity: A T‐Cell‐Independent Pathway of Macrophage Activation, Defined in the scid Mouse , 1991, Immunological reviews.
[31] M. Balboa,et al. Relation between the increase of circulating CD3+ CD57+ lymphocytes and T cell dysfunction in recipients of bone marrow transplantation , 1990, Clinical and experimental immunology.
[32] J. Dumler,et al. Endothelial-cell injury in cutaneous acute graft-versus-host disease. , 1989, The American journal of pathology.
[33] R. Testi,et al. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule , 1989, The Journal of experimental medicine.
[34] J. Farcet,et al. Persistence of T8+/HNK-1+ suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation. , 1986, Journal of immunology.
[35] L. Lanier,et al. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. , 1986, Journal of immunology.
[36] H. Deeg,et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.
[37] H. Deeg,et al. Bone marrow transplantation in patients aged 45 years and older. , 1986, Blood.
[38] R. Guttmann,et al. HNK-1+ (Leu-7) and other lymphocyte subsets in long-term survivors with renal allotransplants. , 1985, Transplantation.
[39] E. Mellits,et al. Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow. , 1984, Blood.
[40] R. Nuscher,et al. Bone marrow transplantation. , 1977, The American journal of nursing.
[41] D. Snover,et al. Hepatic Graft Versus Host Disease: A Study of the Predictive Value of Liver Biopsy in Diagnosis , 1984, Hepatology.
[42] C. Balch,et al. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). , 1981, Journal of immunology.
[43] R Storb,et al. Bone-marrow transplantation (second of two parts). , 1975, The New England journal of medicine.
[44] R Storb,et al. Bone-marrow transplantation (first of two parts). , 1975, The New England journal of medicine.